Real-World Data Show Antibody-Drug Conjugate Still Works in Late-Stage Triple-Negative Breast Cancer
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
